Reasons for Receiving or Not Receiving HPV Vaccination in Primary Schoolgirls in Tanzania: A Case Control Study

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Watson Jones, Deborah ^a,b   Tomlin, Keith ^a   Remes, Pieter ^b,c   Baisley, Kathy ^a   Ponsiano, Riziki ^b   Soteli, Selephina ^b   de Sanjosé, Silvia ^d,e   Changalucha, John ^f   Kapiga, Saidi ^a,b   Hayes, Richard J ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b National Institute for Medical Research   (Tanzania)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

^d CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^e CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^f NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; AGE; ANATOMY; ARTICLE; ATTITUDE TO HEALTH; CANCER PATIENT; CANCER PREVENTION; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; FEMALE; HEALTH EDUCATION; HUMAN; INFERTILITY; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; PARENT; PATIENT ATTITUDE; PHASE 4 CLINICAL TRIAL (TOPIC); PRIMARY SCHOOL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCHOOL CHILD; SOCIAL INTERACTION; SOCIAL STATUS; TANZANIA; UTERINE CERVIX; UTERINE CERVIX CANCER; VACCINATION; VACCINATION REACTION; WART VIRUS; WORM EXPULSION;

ADULT; ALPHAPAPILLOMAVIRUS; CASE-CONTROL STUDIES; CHILD; FEMALE; HUMANS; MALE; PAPILLOMAVIRUS VACCINES; PARENTS; PATIENT ACCEPTANCE OF HEALTH CARE; TANZANIA;

HUMAN PAPILLOMAVIRUS;

EID: 84868142731     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045231     Document Type: Article

References (36)

1. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, et al. (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 87: 796-802.
2. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19.
3. Ferlay JSH, Bray F, Forman D, Mathers C, Parkin DM, (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer Dec 15;127: 2893-917.
4. Paavonen J, Naud P, Salmeron J, Wheeler CM, Chow SN, et al. (2009) Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 374: 301-314.
5. Future I/II Study Group (2010) Dillner J, Kjaer SK, Wheeler CM, Sigurdsson K, et al. (2010) Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ 341: c3493.
6. Future II Study Group (2007) Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 356: 1915-1927.
7. Harper DM, Paavonen J, (2008) Age for HPV vaccination. Vaccine Suppl 1: pp. A7-11.
8. Lazcano-Ponce E, Rivera L, Arillo-Santillan E, Salmeron J, Hernandez-Avila M, et al. (2001) Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca, Mexico. Archives of Medical Research 32: 243-247.
9. Mays RM, Sturm LA, Zimet GD, (2004) Parental perspectives on vaccinating children against sexually transmitted infections. Social Scientist & Medicine 58: 1405-1413.
10. Zimet GD, (2005) Improving adolescent health: focus on HPV vaccine acceptance. Journal of Adolescent Health 37: S17-23.
11. Dempsey AF, Zimet GD, Davis RL, Koutsky L, (2006) Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics 117: 1486-1493.
12. Watson-Jones D, Baisley K, Ponsiano R, Lemme F, Remes P, et al. (2012) HPV vaccination in Tanzanian schoolgirls: cluster-randomised trial comparing two vaccine delivery strategies. J Infect Dis 206: 678-686.
13. Watson-Jones D, Baisley K, Ponsiano R, Remes P, Changalucha J, et al. (2011) HPV vaccination in Tanzania: comparison of two school-based delivery strategies. (Abstract P-02.24). 27th International Papillomavirus Conference, Berlin, 17-22 Sept.
14. Reiter PL, Brewer NT, Gottlieb SL, McRee AL, Smith JS, (2009) Parents' health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med 69: 475-480.
15. Brewer NT, Fazekas KI, (2007) Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med 45: 107-114.
16. Remes P, V. S, Soteli S, Baisley K, Changalucha J, et al. Is HPV vaccination in primary schools acceptable in Tanzanian communities? (Abstract O-09.07) 27th International Human Papillomavirus Conference, Berlin, 17-22 Sept 2011.
17. Niccolai LM, Mehta NR, Hadler JL, (2011) Racial/Ethnic and poverty disparities in human papillomavirus vaccination completion. Am J Prev Med 41: 428-433.
18. Mwandoloma H (2008) Vaccination campaign ends amid reservations. The Guardian, Tues 2 Sept 2008.
19. Progress toward poliomyelitis eradication-Nigeria, January 2007-August 12, 2008. MMWR Morb Mortal Wkly Rep 57: 942-946.
20. Godlee F, Smith J, Marcovitch H, (2011) Wakefield's article linking MMR vaccine and autism was fraudulent. BMJ 342: c7452.
21. Davis K, Dickman ED, Ferris D, Dias JK, (2004) Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis 8: 188-194.
22. Brewer NT, Cuite CL, Herrington JE, Weinstein ND, (2007) Risk compensation and vaccination: can getting vaccinated cause people to engage in risky behaviors? Ann Behav Med 34: 95-99.
23. Brabin L, Roberts SA, Farzaneh F, Kitchener HC, (2006) Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes. Vaccine 24: 3087-3094.
24. Tozzi AE, Rava L, Stat D, Pandolfi E, Marino MG, et al. (2009) Attitudes towards HPV immunization of Italian mothers of adolescent girls and potential role of health professionals in the immunization program. Vaccine 27: 2625-2629.
25. Woodhall SC, Lehtinen M, Verho T, Huhtala H, Hokkanen M, et al. (2007) Anticipated acceptance of HPV vaccination at the baseline of implementation: a survey of parental and adolescent knowledge and attitudes in Finland. J Adolesc Health 40: 466-469.
26. Francis SA, Battle-Fisher M, Liverpool J, Hipple L, Mosavel M, et al. (2011) A qualitative analysis of South African women's knowledge, attitudes, and beliefs about HPV and cervical cancer prevention, vaccine awareness and acceptance, and maternal-child communication about sexual health. Vaccine 29: 8760-8765.
27. Becker-Dreps S, Otieno WA, Brewer NT, Agot K, Smith JS, (2010) HPV vaccine acceptability among Kenyan women. Vaccine 28: 4864-4867.
28. Coleman MA, Levison J, Sangi-Haghpeykar H, (2011) HPV vaccine acceptability in Ghana, West Africa. Vaccine 29: 3945-3950.
29. Trim K, Nagji N, Elit L, Roy K, (2012) Parental Knowledge, Attitudes, and Behaviours towards Human Papillomavirus Vaccination for Their Children: A Systematic Review from 2001 to 2011. Obstet Gynecol Int 2012: 921236.
30. Paul-Ebhohimhen V, Huc S, Tissington H, Oates K, Stark C, (2010) HPV vaccination: vaccine acceptance, side effects and screening intentions. Community Pract 83: 30-33.
31. Giede C, McFadden LL, Komonoski P, Agrawal A, Stauffer A, et al. (2010) The acceptability of HPV vaccination among women attending the University of Saskatchewan Student Health Services. J Obstet Gynaecol Can 32: 679-686.
32. Toffolon-Weiss M, Hagan K, Leston J, Peterson L, Provost E, et al. (2008) Alaska Native parental attitudes on cervical cancer, HPV and the HPV vaccine. Int J Circumpolar Health 67: 363-373.
33. Jaspers L, Budiningsih S, Wolterbeek R, Henderson FC, Peters AA, (2011) Parental acceptance of human papillomavirus (HPV) vaccination in Indonesia: a cross-sectional study. Vaccine 29: 7785-7793.
34. Limia A, Pachon I, (2011) Coverage of human papillomavirus vaccination during the first year of its introduction in Spain. Euro Surveill 16. pii: 19873.
35. Sotiriadis A, Dagklis T, Siamanta V, Chatzigeorgiou K, Agorastos T, (2012) Increasing fear of adverse effects drops intention to vaccinate after the introduction of prophylactic HPV vaccine. Arch Gynecol Obstet 285: 1719-1724.
36. Manhart LE, Burgess-Hull AJ, Fleming CB, Bailey JA, Haggerty KP, et al. (2011) HPV vaccination among a community sample of young adult women. Vaccine 29: 5238-5244.